Clinical Trial Update: A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists [Phase 3]

View source ↗

Summary

Phase 3 clinical trial to evaluate the efficacy and safety of finerenone in heart failure patients who are intolerant or ineligible for steroidal mineralocortic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Colorado Prevention Center | Conditions: Heart Failure | Phase 3 | Status: RECRUITING